Anticipatory prescribing at the end of life in South Edinburgh care homes

Background
• Common symptoms at the end of life include pain, breathlessness, anxiety, respiratory secretions, and nausea. These symptoms can be managed with analgesics, anxiolytics, anti-secretory and anti-emetic medication.
• It can be difficult to obtain medicines quickly for dying residents in care homes unless they are already prescribed. Delays in symptom control are profoundly distressing for patients, family and staff.
• Anticipatory prescribing is advocated in national end of life care strategies to ensure that key medicines are available to manage symptoms that are likely to occur when a patient is dying (Figure 1 ). 
Aim
To explore whether patients in eight South Edinburgh care homes had anticipatory medications prescribed prior to death.
Method
Data was collected in spring 2013 as part of a larger project to improve palliative care in eight care homes. Each care home provided data on anticipatory prescribing for the last ten care home residents who had died. Data on 77 residents was received, 71 of whom died in the care homes (6 died in hospital). 
Conclusions
Barriers to anticipatory prescribing in care homes include:
• Difficulties diagnosing dying
• Lack of knowledge about national anticipatory prescribing guidelines
• Cost concerns relating to wastage of medicines
• Care home staff concerns relating to storage of medications.
Interventions that build the skills and confidence of care home staff to diagnose dying and facilitate anticipatory prescribing are recommended. 
Results
• 41% of residents who died had no anticipatory prescribing in place.
• Anticipatory medicines were most frequently prescribed for analgesia, and least frequently prescribed for nausea and respiratory secretions (Figure 2 ).
• Only 15% of residents who died in care homes had anticipatory prescriptions (AP) for all four common end of life symptoms (Figure 3 ).
